Transaldolase-regulated NADPH production controls inflammation, oxidative stress, and proliferation via the β-catenin/JNK/c-jun pathway and has been proposed as an important metabolic switch in carcinogenesis [32, 33], but the roles of transaldolase in bladder cancer remain unexplored. This evidence concerns the gene MAPK8 and urinary bladder cancer.